Aldo Prawira

机构：SingHealth Duke-NUS Academic Medical Centre · ORCID：0000-0003-4414-6928

发表论文 14 篇 · 总被引 194 次 · h-index 9

代表论文

FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma (2020 · Experimental & Molecular Medicine · 被引 32)
Targeting Treg–fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma (2025 · Gut · 被引 27)
Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype (2018 · Breast Cancer Research and Treatment · 被引 27)
Assessment of PARP4 as a candidate breast cancer susceptibility gene (2019 · Breast Cancer Research and Treatment · 被引 21)
Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma (2020 · Liver International · 被引 19)
Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma (2021 · Hepatology International · 被引 17)